[Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
Robak
T
T
D000818:Animals; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2
Zastosowanie limfocytów aktywowanych interleukina-2 (komórek LAK) w adoptywnej immunoterapii nowotworów.